Factual and Procedural Background
The Competition Appeal Tribunal ("the CAT") dismissed a claim brought by a Class Representative ("the CR" or "the applicant") for aggregate damages under section 47A of the Competition Act 1998 against Company A. The claim, certified as appropriate for a collective opt-out action and upheld by this Court in an earlier ruling, alleged that Company A abused a dominant position by charging excessive and unfair prices for standalone fixed voice ("SFV") landline telephone services to residential customers. Two categories of customers were identified: Voice Only Customers ("VOCs") who purchased SFV services without broadband, and Split Purchase Customers ("SPCs") who purchased SFV services and broadband separately, unlike bundled "Dual Play" ("DP") customers.
The claim's core was that Company A's SFV prices were excessive compared to the cost of provision, violating section 18 of the Competition Act 1998. The CAT applied a two-limb test: Limb 1 assessed whether prices exceeded a Cost-Plus benchmark (cost plus an appropriate return), and Limb 2 evaluated whether any excess was justified by economic value. The CAT identified liability issues including market definition, dominance, excess pricing, and justification, as well as quantum issues concerning mitigation, quantification, class size, inflation, and interest.
Despite initial appearances favoring the applicant—such as a provisional regulatory finding of overcharging and Company A's remedial actions—the CAT, after a 28-day trial, concluded that although Company A was dominant and prices exceeded Cost-Plus, the excess was justified under Limb 2, rendering the pricing fair and dismissing the claim. The applicant sought permission to appeal, which the CAT refused, leading to this application for permission to this Court.
Legal Issues Presented
- Whether the CAT erred in its approach to the calculation of indirect costs and the drawing of adverse inferences regarding Company A's failure to produce relevant cost data.
- Whether the CAT irrationally relied on the Stand-Alone Costs Combinatorial ("SAC Combi") test in attributing 40% of Company A's common costs to SFV services.
- Whether the CAT made errors in its evaluation of whether the pricing differential bore a reasonable relation to economic value, including its treatment of switching, distinctive value, and specific product features ("Gives") and brand value.
- Whether the CAT erred in holding that it could not award compound interest.
Arguments of the Parties
Appellant's Arguments
- The CAT wrongly failed to draw adverse inferences against Company A for not producing indirect cost data, improperly placing the evidential burden on the applicant and giving undue weight to Company A's expert evidence.
- The attribution of 40% of common costs to SFV services was irrational, inconsistent with prior case law, and improperly relied on a flawed SAC Combi methodology.
- The CAT misdirected itself in assessing whether the pricing differential was justified by economic value, including errors regarding the significance of the excess, failure to consider a competitive market context, misapplication of the willingness to pay fallacy, and flawed treatment of switching, distinctive value, Gives, and brand value.
- The CAT erred in concluding it could not award compound interest, an issue contingent on success on appeal and damages being awarded.
Table of Precedents Cited
| Precedent |
Rule or Principle Cited For |
Application by the Court |
| Astra Zeneca v Commission (Case C-457/10) |
Market share thresholds for presumption of dominance |
The CAT relied on this to uphold a presumption of dominance based on Company A's market shares exceeding 50%. |
| Hoffman-La Roche v Commission |
Possession of a large market share as proof of dominance |
Supported the CAT's finding that sustained large market shares indicate dominance. |
| AKZO v Commission |
Market shares over 50% constitute very large market shares |
Used to affirm the presumption of dominance at the 50% market share threshold. |
| Airwave Solutions Limited v CMA [2025] EWCA Civ 54 |
Review of errors in evaluation of evidence as potential errors of law |
Guided the Court's approach to the limited scope of appellate interference in evaluative judgments. |
| Sainsbury's Supermarkets Ltd v Visa Europe Services LLC [2020] UKSC 24 |
Evidential burden on defendants in pricing cases and adverse inferences |
Referenced in assessing whether the CAT should have drawn adverse inferences from Company A's failure to produce cost data. |
| Royal Mail Group Ltd v DAF Trucks Ltd [2024] EWCA Civ 181 |
Evidential burden and disclosure obligations |
Supported the argument concerning evidential burdens in cartel and pricing cases. |
| PSA Automobiles SA v Autoliv AB [2025] CAT 9 |
Drawing adverse inferences for failure to adduce relevant evidence |
Applied analogously to the failure to produce cost evidence by Company A. |
| CMA v Flynn Pharma Limited and Others [2020] EWCA Civ 339 |
Evidential burden in excessive pricing cases |
Recognized the defendant's important evidential burden in justifying pricing differentials. |
| Phones 4U Limited v EE Limited and others [2025] EWCA Civ 869 |
Limits on drawing adverse inferences for failures in document preservation |
Used to illustrate the discretion and rationality required before drawing adverse inferences. |
| Efobi v Royal Mail Group Ltd [2021] UKSC 33 |
Rationality and common sense in drawing inferences |
Emphasized the fact-specific and discretionary nature of adverse inferences. |
| Malhotra v Dhawan [1997] EWCA 1096 |
Balance in applying adverse inference doctrines |
Guided the Court's approach to weighing adverse inferences against other evidence. |
| Fairchild v Glenhaven [2002] UKHL 22 |
Evidential burden on parties controlling evidence |
Supported the principle that evidence should be weighed considering which party had control over it. |
| BT v Ofcom [2011] CAT 5 ("PPC") |
Principles on combinatorial cost allocation tests |
Referenced in evaluating the CAT's use of SAC Combi and its consistency with established principles. |
| Cinven Capital Management and others v CMA [2025] EWCA Civ 578 |
Methodology for assessing unfair pricing and evidential burdens |
Provided a recent framework for the Cost-Plus and Limb 2 tests and evidential burdens on defendants. |
| Generics (UK) Ltd and Others v CMA (Case C-307/18) |
Role of justification evidence in excessive pricing cases |
Explained the evidential burden on defendants to justify pricing differentials. |
| Phenytoin case |
Willingness to pay fallacy in excessive pricing |
Clarified that consumer payment does not automatically justify price fairness in dominance cases. |
Court's Reasoning and Analysis
The Court recognized the CAT's role as a fact-finder with specialized expertise in evaluating complex economic, financial, and legal evidence, particularly in the context of Cost-Plus pricing and justification under section 18 CA 1998. The Court emphasized the limited scope of appellate review to points of law, especially given the evaluative and judgment-based nature of the CAT's findings.
Regarding the failure of Company A to produce specific indirect cost data, the Court found that the CAT was entitled to reject the applicant's submission that an adverse inference should be drawn. The CAT had critically evaluated the expert evidence, acknowledged deficiencies, and struck a balance between competing expert methodologies. The CAT's decision to rely to a limited extent on Company A's expert, despite methodological weaknesses caused by lack of data, was within its discretion and not irrational.
On the allocation of 40% of common costs to SFV services, the Court held that the CAT's approach was a reasoned, pragmatic judgment. The CAT did not fully endorse the SAC Combi test but used it as one input among others to reach a balanced conclusion. The Court found no inconsistency with prior case law and no irrationality in the CAT's reasoning or adoption of a "broad axe" approach to complex cost allocation.
In assessing whether the pricing differential bore a reasonable relation to economic value (Limb 2), the Court noted that the CAT conducted a detailed, fact-sensitive analysis. The CAT considered switching behavior, customer engagement, and the concept of "distinctive value," concluding that some customers valued SFV services and brand loyalty justified the excess to a degree. The Court rejected the applicant's argument that the CAT committed the willingness to pay fallacy, explaining that the CAT properly distinguished between captive and non-captive markets and made findings supported by evidence.
The Court also held that the CAT reasonably evaluated the product features ("Gives") and brand value as contributing to justification. The CAT's inability to quantify precisely the cumulative value was not fatal given the nature of the evidence and the reasonableness standard applied. Allegations of double counting and inadequate reasoning were dismissed as challenges to factual findings outside the Court's jurisdiction or as insufficient to show error of law.
Finally, the Court found the issue of compound interest to be academic given the refusal of permission to appeal and the absence of a damages award.
Holding and Implications
Permission to appeal is refused.
The Court upheld the CAT's dismissal of the claim for aggregate damages against Company A for alleged excessive pricing in the SFV services market. The CAT's detailed and nuanced findings on market dominance, cost allocation, and justification under the two-limb test were affirmed as lawful and reasonable. The refusal to award compound interest was not addressed substantively due to the refusal of permission.
This decision directly affects the parties by concluding the litigation at this appellate stage without setting new legal precedent, reaffirming the established principles governing appellate review of complex competition pricing cases and the evidential burdens on dominant undertakings in justifying prices above Cost-Plus benchmarks.